FDA Inspection 961861 — AstraZeneca Dunkerque Production (AZDP)
The FDA completed an inspection of AstraZeneca Dunkerque Production (AZDP) on Nov 20, 2015 in Dordogne. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 20, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dordogne (France)